Abbott's Xience Prime & Xience V coronary stent system get new CE markings to treat patients with diabetes
Wednesday, November 04, 2009 15:00 IST Brussels, Belgium
Abbott announced that both the Xience Prime Everolimus Eluting Coronary Stent System and the Xience V Everolimus Eluting Coronary Stent System have received additional new CE Markings